Literature DB >> 8916954

The c-kit ligand potentiates the allogeneic mixed lymphocyte reaction.

E M Bluman1, G S Schnier, B R Avalos, M P Strout, H Sultan, F W Jacobson, D E Williams, W E Carson, M A Caligiuri.   

Abstract

The allogeneic mixed lymphocyte reaction (MLR) is a complex in vitro assay of T-cell recognition and responsiveness in which interleukin-2 (IL-2) plays a central role. We have previously demonstrated that c-kit ligand (KL) can enhance IL-2-induced proliferation in a subset of human natural killer cells expressing the c-kit tyrosine kinase receptor. In the present study, we asked whether KL could enhance IL-2-mediated T-cell proliferation in the allogeneic MLR. We demonstrate that the vast majority of activated human T-cell clones express the c-kit mRNA transcript. Binding studies performed on activated T cells with radioiodinated KL were consistent with the expression of a single class of c-kit receptors. The addition of exogenous KL to the MLR led to an increase in tritiated thymidine (3[H]-TdR) incorporation in the absence of other exogenous cytokines, and did so in a dose-dependent fashion. A reproducible increase in 3[H]-TdR incorporation was noted at concentrations of KL, which approximate those normally found in vivo. Antibody blocking of KL binding to c-kit, T-cell depletion and sorting experiments suggest that the action of KL is mediated at least in part by a direct effect on both CD4+ and CD8+ T-cells. KL's enhancement of the MLR also requires the binding of IL-2 to its high-affinity IL-2 receptor. Given the abundance of KL normally found in human serum, these data suggest that this cytokine may have a role during T-cell activation in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916954

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  NK1.1+ cells and IL-22 regulate vaccine-induced protective immunity against challenge with Mycobacterium tuberculosis.

Authors:  Rohan Dhiman; Sivakumar Periasamy; Peter F Barnes; Ankita Garg Jaiswal; Padmaja Paidipally; Amanda B Barnes; Amy Tvinnereim; Ramakrishna Vankayalapati
Journal:  J Immunol       Date:  2012-06-18       Impact factor: 5.422

2.  rFliC prolongs allograft survival in association with the activation of recipient Tregs in a TLR5-dependent manner.

Authors:  Jing Hao; Chao Zhang; Ting Liang; Jing Song; Guihua Hou
Journal:  Cell Mol Immunol       Date:  2013-10-07       Impact factor: 11.530

3.  The Suppressed Induction of Human Mature Cytotoxic T Lymphocytes Caused by Asbestos Is Not due to Interleukin-2 Insufficiency.

Authors:  Naoko Kumagai-Takei; Yasumitsu Nishimura; Hidenori Matsuzaki; Suni Lee; Kei Yoshitome; Hiroaki Hayashi; Takemi Otsuki
Journal:  J Immunol Res       Date:  2016-11-15       Impact factor: 4.818

4.  CD117 (c-Kit) Is Expressed During CD8+ T Cell Priming and Stratifies Sensitivity to Apoptosis According to Strength of TCR Engagement.

Authors:  Guido Frumento; Jianmin Zuo; Kriti Verma; Wayne Croft; Pradeep Ramagiri; Frederick E Chen; Paul Moss
Journal:  Front Immunol       Date:  2019-03-15       Impact factor: 7.561

5.  Effect of IL-15 addition on asbestos-induced suppression of human cytotoxic T lymphocyte induction.

Authors:  Naoko Kumagai-Takei; Yasumitsu Nishimura; Hidenori Matsuzaki; Suni Lee; Kei Yoshitome; Tatsuo Ito; Takemi Otsuki
Journal:  Environ Health Prev Med       Date:  2021-04-19       Impact factor: 3.674

6.  A high-efficiency system of natural killer cell cloning.

Authors:  Rebecca J Morris; Lee K Chong; Gavin W G Wilkinson; Eddie C Y Wang
Journal:  J Immunol Methods       Date:  2005-10-21       Impact factor: 2.303

7.  Runx3-mediated transcriptional program in cytotoxic lymphocytes.

Authors:  Joseph Lotem; Ditsa Levanon; Varda Negreanu; Dena Leshkowitz; Gilgi Friedlander; Yoram Groner
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.